Results 601-620 of 1,133,849 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Tom Kitt OR speaker:Josepha Madigan OR speaker:Ruairi Ó Murchú OR speaker:Seán Canney OR speaker:John Lahart OR speaker:Marc Ó Cathasaigh OR speaker:Marc MacSharry OR speaker:Michael McGrath OR speaker:Ivana Bacik OR speaker:Cathal Crowe OR speaker:Michael Ring OR speaker:Seán Ó Fearghaíl OR speaker:Patricia Ryan OR speaker:Colm Brophy OR speaker:James Browne OR speaker:Holly Cairns OR speaker:Michael Creed OR speaker:David Cullinane OR speaker:Catherine Martin OR speaker:Donnchadh Ó Laoghaire OR speaker:Pa Daly OR speaker:Richard Boyd Barrett OR speaker:Mark Ward OR speaker:Bernard Durkan OR speaker:Paschal Donohoe OR speaker:Claire Kerrane OR speaker:Martin Heydon OR speaker:Éamon Ó Cuív OR speaker:Éamon Ó Cuív04 OR speaker:Neasa Hourigan OR speaker:Thomas Gould OR speaker:Aindrias Moynihan OR speaker:Paul Donnelly)
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: Dr. Kelly mentioned at the start he made on 13 recommendations to the citizens' assembly. Were they all accepted or were any barriers faced in getting some of them accepted?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: Did Dr. Kelly meet any barriers when speaking at the citizens' assembly? What was the feedback on the recommendations he put forward?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: Professor Comiskey said we should enable evidence-informed policy and nurse-led prescribing and she has research to support that. She said she wanted to expand on that research.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: It is anecdotal.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: It is fantastic. I thank the Chair.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: I was not sure what the time was, but I am fine.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I welcome our witnesses. I want to touch on stigma but before that I will go back to nurse prescribing. A lot of the discussion we are having today reminds me of when I followed the nurse prescribing journey in diabetes. It reminds me of that a lot, in that it is a lifestyle-based treatment and is very much about who you meet when you go into a clinic. At the front line that is often...
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I presume we should have non-elective modules within training for all medical professionals. Would that be specifically on addiction or would it be more useful for it be about what trauma-centred care looks like?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Would the other witnesses like to come in on addiction versus trauma led?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: The research suggests that when you are on the front line, those attitudes become more prevalent.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: That would take care of all of our new cohort. There are hundreds of thousands of people working in services that are central or tangential to our health service. How do we hit all of them? Do we need to get everybody into a continuing professional development course on addiction and trauma-like care?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: How far along are we on that journey?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Working in an emergency department is different from working in a laboratory.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I will return to the question of the inspection of services. I am a member of the Joint Committee on Health, where we talk a lot about the inspection side of things in the context of oversight, performance indicators and outcomes. Who would do that? Perhaps that is not fair. What kind of a body could the witnesses imagine undertaking that piece of work?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Could Dr. Kelly give me an idea of the breadth and level of that service? Would it include all the third-party and NGO services?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Would it influence how drug task forces work?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: It is crazy.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: By proxy, there would be a benchmark that you could fall below and therefore-----
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: I will not say what popped into my head. Just taking the piss.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: Not once or twice weekly, however. There is no benefit there.